Vaginal Sling Market Report 2026

Vaginal Sling Market Overview

• Vaginal Sling market size has reached to $1.6 billion in 2025 • Expected to grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Impact Of The Growing Female Geriatric Population On The Vaginal Sling Market • Market Trend: Innovative Solutions In The Vaginal Slings Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vaginal Sling Market?

A vaginal sling refers to a mesh implant used to strengthen ligaments and connective tissue structures that assist in managing urine incontinence. The vaginal sling procedure is one therapy option for female stress urine incontinence. The main product types of the vaginal sling are transobturator slings, tension-free vaginal tape slings and others. Transobturator slings refer to a surgical method to treat stress urinary incontinence that makes use of a thin strip of permanent mesh. The various material types include tissue slings and synthetic slings with various types of urinary incontinence including stress urinary incontinence, urge urinary incontinence and mixed urinary incontinence. These are used by various end-users such as hospitals, clinics and others.

What Is The Vaginal Sling Market Growth Forecast?

The vaginal sling market size is expected to see strong growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for outpatient incontinence surgeries, rising focus on patient safety and biocompatibility, expansion of female healthcare services, growing adoption of minimally invasive gynecological procedures, increasing healthcare spending on women’s health. Major trends in the forecast period include increasing adoption of minimally invasive sling procedures, rising demand for synthetic and lightweight mesh materials, growing preference for adjustable sling systems, expansion of outpatient incontinence treatment options, enhanced focus on long-term implant safety.

Global Vaginal Sling Market Segmentation

1) By Product Type: Transobturator Slings, Tension-Free Vaginal Tape Sling 2) By Material-Type: Tissue Slings, Synthetic Slings 3) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Transobturator Slings: Adjustable Transobturator Slings, Non-adjustable Transobturator Slings 2) By Tension-free Vaginal Tape Sling: Standard Tension-free Vaginal Tape, Specialty Tension-Free Vaginal Tape

What Is The Driver Of The Vaginal Sling Market?

The growing female geriatric population is expected to propel the growth of the vaginal sling market going forward. The female geriatric population refers to the older population (65 years and beyond). A portion of the growing female geriatric population is affected by stress urinary incontinence (SUI) and other urinary incontinence, which is treated and controlled by vaginal slings. For instance, in January 2023, according to a report published by the Statistics Netherlands, a Netherlands-based government agency, as of January 2023, the female population in the Netherlands totaled 2,172 residents. Among individuals aged 90 and above, there are 95,090 women and 40,128 men. Therefore, the growing female geriatric population is driving the growth of the vaginal sling industry going forward.

Key Players In The Global Vaginal Sling Market

Major companies operating in the vaginal sling market are Boston Scientific Corporation, Coloplast A S, B Braun Melsungen AG, Caldera Medical Inc, Promedon GmbH, Teleflex Inc, W L Gore Associates Inc, Degania Medical Devices Pvt Ltd, Lotus Surgicals Pvt Ltd, Urotech Co Ltd, Betatech Medical Inc, ABISS Pty Ltd, Neomedic International Ltd, Prosurg Inc, A M I GmbH, Cousin Biotech, Herniamesh S R L, Peters Surgical, Aspide Medical, BioCer Entwicklungs GmbH, FemmeMesh Medical

Global Vaginal Sling Market Trends and Insights

Major companies operating in the vaginal slings market are developing innovative products such as treatments for stress urinary incontinence (SUI) to meet larger customer bases, more sales, and increase revenue. The treatment for Stress Urinary Incontinence (SUI) involves various approaches aimed at addressing the underlying causes and managing the symptoms of involuntary urine leakage that occurs during activities such as coughing, sneezing, laughing, or physical exertion. For instance, in January 2024, UroCure LLC, a US-based women’s health company, and LiNA Medical USA, a US-based minimally invasive gynecology device company, launched two surgical solutions for female stress urinary incontinence: the ArcSP suprapubic sling system and the ArcTO transobturator sling system. ArcSP will now provide a top-down, retropubic approach, and ArcTO will accommodate surgeons that prefer an outside-in, transobturator approach.

What Are Latest Mergers And Acquisitions In The Vaginal Sling Market?

In March 2025, Caldera Medical, a US based provider of women’s health medical devices, acquired the Ethicon GYNECARE TVT family of products for an undisclosed amount. With this acquisition, Caldera Medical gains access to the GYNECARE TVT product line, a well-established suite of minimally invasive slings for the treatment of stress urinary incontinence, thereby enhancing its surgical women’s health portfolio, expanding its global reach, and improving its operational scale. Ethicon is a US based provider of surgical systems and instruments, is known for its long-standing leadership in mid urethral sling therapies and the GYNECARE TVT franchise.

Regional Outlook

North America was the largest region in the Vaginal Slings market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vaginal Sling Market?

The vaginal sling market consists of sales of allograft slings, mid-urethral retropubic slings, single-incision slings, and mini slings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.